This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When over-the-counter (OTC) remedies don’t cut it, your healthcare provider may prescribe Zofran ( ondansetron ), a medication used to treat upset stomach and prevent vomiting—especially when caused by chemotherapy, radiation therapy, and surgery. It’s also can be used off-label to treat morning sickness during pregnancy.
The European Commission has approved Tecartus (brexucabtagene autoleucel) for adults aged 26 and over with relapsed or refractory B-cell precursor ALL, a patient population not covered by the label for Novartis’ CD19 CAR-T Kymriah (tisagenlecleucel), which covers paediatric and young adult patients up to age 25.
The prospective, open-label, single-arm, Phase II TUXEDO-1 study enrolled 14 women and one man with human epidermal growth factor receptor 2 (HER2)-positive breast cancer and newly diagnosed untreated brain metastases or brain metastases progressing after previous local therapy.
4,5 Polypharmacy – daily use of five or more drugs – is common in these patients and increases the risk of DRPs, which can result in adverse outcomes such as postoperative complications, chemotherapy toxicities and functional decline. 10,11 This can be due to side effects of chemotherapy or the addition of certain supportive care medications.
Suitable for all women with advanced ovarian cancer, regardless of BRCA mutation status, who have responded to first-line platinum-based chemotherapy, rucaparib (brand name Rubraca) is a poly-ADP ribose polymerase (PARP) inhibitor. Dr Rebecca Kristeleit, consultant medical oncologist and adjunct reader at Guy’s and St.
In human patients, it’s used to treat vomiting and nausea due to cancer chemotherapy or radiation therapy. Veterinarians commonly use ondansetron for chemotherapy, but its use in dogs is “ off-label.” Nausea-inducing chemotherapy is a common reason veterinarians give dogs ondansetron.
Some 217 patients with R/R follicular lymphoma who had received at least two prior lines of systemic therapy were included in the global, randomised, open-label study. Brukinsa is a chemotherapy-free, oral treatment option that can be a practice-changing option for eligible patients with relapsed or refractory follicular lymphoma.’
Ondansetron for cats is an extra-label use of the drug. The most common reasons ondansetron is needed in cats are chemotherapy, drug treatment, and pancreatitis (inflamed pancreas). Chemotherapy and drug-induced vomiting Like dogs and humans, cats can get malignant cancers that require chemotherapy.
Adagrasib is a monotherapy indicated for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation who have progressive disease after prior therapy with, or intolerance to, platinum-based chemotherapy and/or anti-PD-1/PD-L1 immunotherapy.
I think I first realized it when I was working at my first hospital. My hospital had a unique financial blueprint. It seemed that they paid bills when they wanted to Many companies didn’t like this arrangement and wouldn’t do business with our hospital. Possession ruled the departments of my hospital. But some did.
Antiemetics may also reduce radiation-associated or chemotherapy-induced nausea resulting from cancer treatment. Be sure to follow the dosing instructions on the label for your child’s age. Antiemetic side effects Most OTC antiemetics are well-tolerated and safe if taken according to the labeled instructions.
For this reason, its use in dogs is off-label. Veterinarians may use it in a cat to prevent nausea and vomiting due to chemotherapy. So, read labels carefully. If a dog is given too much mirtazapine, call an animal poison control center, talk to the veterinarian, or take the dog to a veterinary hospital.
Injectable formulations of methotrexate are utilized as chemotherapy against various cancers. Humira is another TNF inhibitor , but it can be given by subcutaneous injection at home rather than requiring an intravenous infusion at an office or hospital like Remicade.
This global, multi-centre, open-label, Phase 3 study, evaluated Trodelvy versus the physician’s choice of chemotherapy (eribulin, capecitabine, gemcitabine or vinorelbine). as assessed by blinded independent central review for participants treated with Trodelvy compared to those treated with chemotherapy.
In fact, trastuzumab in combination with chemotherapy is a treatment option for patients with HER2-positive advanced gastric cancer. In a second phase 2 trial with HER2-positive advanced gastric cancer patients, researchers compared T-Dx-T with a physician’s choice of chemotherapy. months a progression-free survival of 5.6
The use of adjunctive alectinib reduced disease recurrence in the early setting for people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) compared to platinum-based chemotherapy, its manufacturer Roche has announced. The OS data were immature at the time of the interim analysis.
Professor Alain Astier discusses how the tradition of manufacturing drugs in hospitals and hospital pharmacies is taking on new directions in light of increasing medicine shortages, enhanced professional responsibilities for pharmacists and the shift towards delivering personalised medicine. Making drugs is old-fashioned!
There’s also some evidence that high doses of melatonin given to cancer patients in conjunction with treatment like chemotherapy may help shrink tumors and improve survival rates. Short-term use of melatonin is typically considered safe in healthy adults, says Nicole Roach , a registered dietitian at Lenox Hill Hospital New York.
chemotherapy-induced), pain, and post-traumatic stress disorder. chemotherapy-induced), and pain. FDA and HHS concluded that “there exists some credible scientific support for the medical use” in the U.S. chemotherapy-induced), and pain. chemotherapy-induced), and pain.
At ASH, the E1910 clinical trial generated results could unlock a new patient population for Blincyto, after it was shown to improve overall survival in patients with no measurable residual disease (MRD) after induction chemotherapy for B-ALL. “It’s a huge step forward for treating this devastating disease.”
What, if Any, Risk There Is to the Public Health HHS found based on an evaluation of various epidemiological databases for emergency department visits, hospitalizations, unintentional exposures, and overdose deaths that public health risks posed by marijuana are low compared to other drugs of abuse. chemotherapy-induced), and pain.
Orthostatic hypotension can lead to falls and fainting—and in some cases, fractures and hospitalizations have been reported. How does Cymbalta work for anxiety? Researchers note that Cymbalta (duloxetine) works for anxiety because it targets two essential brain chemical messengers (neurotransmitters): serotonin and norepinephrine.
Regeneron has announced that the European Commission (EC) has approved Libtayo (cemiplimab) as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The results were published in the New England Journal of Medicine.
A total of 1,074 patients underwent randomisation in a 2:2:1 ratio to receive amivantamablazertinib (open-label), osimertinib (blinded), or lazertinib (blinded, to assess the contribution of treatment components). The primary endpoint was progression-free survival in the amivantamablazertinib group as compared with the osimertinib group.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content